Literature DB >> 1947772

Disappearance of gastritis after eradication of Helicobacter pylori. A morphometric study.

J Valle1, K Seppälä, P Sipponen, T Kosunen.   

Abstract

Helicobacter pylori infection is strongly associated with and is considered a common cause of gastritis. To study the relationship between H. pylori and gastritis, we examined whether a reduction occurs in acute granulocytic and chronic mononuclear inflammation of gastric mucosa after eradication therapy. The examination is based on morphometric counting and on semiquantitative estimation of the density of the inflammatory cells in endoscopic biopsy specimens from antrum and corpus. The series consisted of 23 consecutive outpatients with H. pylori-associated gastritis who received a 2-week course of triple therapy with colloidal bismuth subcitrate, amoxicillin, and metronidazole and who underwent an endoscopic follow-up for 6 weeks, 6 months (23 patients), and 12 months (21 patients). The eradication was successful in 20 patients ('responders'), who also remained H. pylori-free for 6 months, and in 18 examined patients for 12 months but was unsuccessful in 3 patients ('non-responders'). Both acute and chronic inflammation decreased significantly in intensity in responders in the follow-up. The acute inflammation had already disappeared at a 6-week control. The reduction in chronic inflammation was slower and occurred gradually within the study. At the 12-month follow-up, the corpus mucosa was interpreted as normal in all 18 patients studied, and the antral mucosa was interpreted as normal in 10 (56%) patients. No significant reduction in intensity of gastritis was found in the 3 non-responders or the 23 matched, untreated controls. We conclude that the eradication of H. pylori results in a disappearance of both acute and chronic gastritis. This supports the view that H. pylori plays a causal role in the pathogenesis of chronic gastritis.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1947772     DOI: 10.3109/00365529109003956

Source DB:  PubMed          Journal:  Scand J Gastroenterol        ISSN: 0036-5521            Impact factor:   2.423


  25 in total

1.  Role of metronidazole resistance in therapy of Helicobacter pylori infections.

Authors:  H Rautelin; K Seppälä; O V Renkonen; U Vainio; T U Kosunen
Journal:  Antimicrob Agents Chemother       Date:  1992-01       Impact factor: 5.191

2.  Rebamipide reduces recurrence of experimental gastric ulcers: role of free radicals and neutrophils.

Authors:  Kazushi Sakurai; Toshihiro Osaka; Katsuya Yamasaki
Journal:  Dig Dis Sci       Date:  2005-10       Impact factor: 3.199

Review 3.  Eradication of Helicobacter pylori should be pivotal in managing peptic ulceration. Eradication largely prevents relapse.

Authors:  C J Hawkey
Journal:  BMJ       Date:  1994-12-10

4.  Long-term follow-up study of gastric emptying and Helicobacter pylori eradication among patients with functional dyspepsia.

Authors:  J Koskenpato; T Korppi-Tommola; K Kairemo; M Färkkilä
Journal:  Dig Dis Sci       Date:  2000-09       Impact factor: 3.199

5.  Antigastric autoantibodies in ferrets naturally infected with Helicobacter mustelae.

Authors:  T O Cróinín ; M Clyne; B J Appelmelk; B Drumm
Journal:  Infect Immun       Date:  2001-04       Impact factor: 3.441

6.  Effect of metronidazole resistance on bacterial eradication of Helicobacter pylori in infected children.

Authors:  J Raymond; N Kalach; M Bergeret; P H Benhamou; J P Barbet; D Gendrel; C Dupont
Journal:  Antimicrob Agents Chemother       Date:  1998-06       Impact factor: 5.191

7.  Density of gastric Helicobacter pylori colonization is not associated with occurrence of dyspeptic symptoms.

Authors:  B Braden; W F Caspary; B Lembcke
Journal:  Dig Dis Sci       Date:  1997-10       Impact factor: 3.199

8.  Effect of ranitidine bismuth citrate on postprandial plasma gastrin and pepsinogens.

Authors:  A G Fraser; W M Lam; Y W Luk; J Sercombe; A M Sawyerr; M Hudson; I M Samloff; R E Pounder
Journal:  Gut       Date:  1993-03       Impact factor: 23.059

9.  Diagnosis of Helicobacter pylori infection by using pyloriset EIA-G and EIA-A for detection of serum immunoglobulin G (IgG) and IgA antibodies.

Authors:  C Granberg; A Mansikka; O P Lehtonen; H Kujari; R Grönfors; H Nurmi; I Räihä; M R Ståhlberg; R Leino
Journal:  J Clin Microbiol       Date:  1993-06       Impact factor: 5.948

10.  Features of gastritis predisposing to gastric adenoma and early gastric cancer.

Authors:  A Meining; B Riedl; M Stolte
Journal:  J Clin Pathol       Date:  2002-10       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.